All Industries

Ride the Crypto Bull Run: Dive into HTX's Enhanced Flexible Products and Dual Investment with Expanded Offerings, Enjoying Up to 10% APY

HTX

Bitcoin has tested the $70,000 mark several times, fueling persistent FOMO sentiment in the market, while an array of new protocols and staking opportunities emerge. In the current crypto bull market, HTX Earn offers a variety of robust products to help investors achieve financial growth. With distinct advantages, these products offer a diverse range of offerings, high APYs, and low entry barriers. Users can choose products based on their financial situation as each of HTX Earn's products has its features. Quick and Easy Access to Simple Earn, with Products Offering up to 10% APY HTX Earn's Flexible products are continuously broadening their selection to include more popular cryptocurrencies, empowering users to capitalize on the appreciation of high-quality cryptos while earning returns. Additionally, these Flexible products offer exceptional flexibility, allowing users to deposit and withdraw funds at their convenience. According to HTX's official announcement, HTX Earn has recently introduced new Flexible products for PEPE, BOME, SLERF, DEGEN, and WIF, boasting up to 10% APY. To subscribe to these products, you can access them either through HTX's official website or app. Please follow the steps below. Website: Log in to HTX's official website > click "Earn" on the navigation bar > select "Flexible, Fixed" in the dropdown menu. App: Log in to your HTX App > tap "Earn" on the main page > select "Simple Earn". Compared to Traditional Offerings, HTX's Structured Products Provide Higher Annualized Earnings HTX Structured Products is an innovative financial instrument that includes assets linked to fixed income and derivatives to meet the personalized needs of investors with different risk preferences and return expectations. These products feature higher APYs and zero fees, catering to users with risk tolerance, professional investors, and institutions. This category encompasses two products: Dual Investment and Shark Fin. Dual Investment is a non-principal-protected structured product that consists of two cryptocurrencies. It empowers investors with the flexibility to select a target price and date, allowing them to capitalize on opportunities to purchase the specified cryptocurrency at a lower price or sell it at a higher value in the future. The Dual Investment product is non-principal protected and generates floating earnings. It allows you to gain returns by investing in one of the cryptos, such as BTC, ETH, AVAX, and SOL. At present, HTX Earn has updated its Dual Investment products, adding LTC, DOT, LINK, and MATIC offerings. This expansion broadens the range of choices available to users. Shark Fin is the flagship product of HTX Earn, and its pattern can be either bullish or bearish. What sets Shark Fin apart is its unique ability to enable investors to secure basic returns while potentially pursuing more profits based on market fluctuations. Additionally, these products are characterized by flexibility and short investment cycles without affecting fund liquidity. Users' returns from Shark Fin are determined by the accuracy of their predictions about future market trends. During the first quarter of 2024, 15 rounds of 7-day Shark Fin products were issued, amassing a total subscription amount of $1.5 billion, with the highest APY reaching 60%. Users can make subscriptions by navigating to "HTX Earn" > "Shark Fin" during the subscription period. As a world-leading digital asset trading platform, HTX has maintained a secure operation for eleven years. HTX Earn serves as a dependable instrument for the management of virtual assets, presenting a wide range of products that align with users' requirements. It guarantees the utmost security of assets, thanks to the exchange's robust risk management system. Furthermore, HTX Earn is purpose-built to deliver top-tier assets for daily passive income, coupled with a user-friendly interface that ensures a seamless and convenient wealth management experience. About HTX Founded in 2013, HTX has evolved over a decade from a simple cryptocurrency exchange to a comprehensive blockchain business ecosystem. This expansion covers a wide range of services including digital asset trading, financial derivatives, wallets, research, investments, incubation, and more. As a world-leading portal to Web 3.0, HTX is committed to a growth strategy focused on global expansion, ecological prosperity, wealth effect, and safety and compliance. This approach enables us to offer comprehensive, safe, and reliable services and value to virtual currency enthusiasts around the world, reinforcing our position as a global gateway to Web3. Contact Details Michael Wang glo-media@htx-inc.com Company Website https://www.htx.com/

April 17, 2024 11:24 AM Eastern Daylight Time

News Release

TOWER CAPITAL GROUP Reveals Esteemed Multidisciplinary Generational Health Advisors

TOWER CAPITAL GROUP

TOWER CAPITAL GROUP, market maker of Generational Health, is proud to announce the addition of nine new members to its esteemed Advisory Team. Generational Health are those effects passed on genetically, epigenetically, and environmentally, shaping humanity’s evolutionary curve. It represents a multi trillion-dollar opportunity encompassing critical areas of community, environment, and women’s health. TOWER’s Advisory Team includes expertise across more than 10 industry categories including Digital Health, Energy, Life Sciences, Pharmacy, AI & Data, Veterans’ Health, Venture Capital, Women’s Health, and more. These experts come from across the United States and include Entrepreneurs, Strategic Operators, Corporate Executives, and Funders. The appointment of these industry leaders demonstrates the strategic and execution capacity of TOWER CAPITAL GROUP as it supports the growth of its published cohort of > $17B USD Generational Health entities, as measured by total current capital invested. As summarized by TOWER’s Capital Markets and Community expert, Philip Benjamin, “Generational Health supports a framework for my clinical and advocacy work in children’s health and safety with an understanding that their wellbeing extends to those that care for children, the community, and the environment at large.” Further shared by TOWER’s Medicine and Health Systems expert, Dr. Jennifer Kahoud, “As an ER doctor on the front lines of a broken city, we are not asking the right questions to bring about necessary change. A multidisciplinary approach to Generational Health is a bold call for accountability to ask and answer the right questions.” Additionally, Tom Cassels (Life Science & Digital Health), Stephanie Lasker (Operating Excellence for Scaling Startups), Charlie Lieu (Big Data & Systems Biology), Justin Nahama (Military & Veteran Health), Alpa Saluja (Clinical Insight), Naseem Sayani (Early Stage Venture Capital), and Dorothea Soule (Energy & Commercialization) all represent rigor and intelligence across the many disciplines of Generational Health. Operating across industries, regions and partners, TOWER CAPITAL GROUP and its affiliates deploy expertise and capital to uncover economic value, investment and innovation within Generational Health and bring it to stakeholders across the globe. Visit www.towercapital.org for more information on Generational Health, the Company, and its mission. Investor Inquiries: Sheri Bailey sheri@towercapital.org Contact Details For Media Inquiries please contact TOWER CAPITAL GROUP contact@towercapital.org

April 17, 2024 11:00 AM Eastern Daylight Time

MJ ATTACHÉ LAUNCHES BUSINESS WITH DEBUT OF FIRST-OF-ITS-KIND LUXURY CACHE-AND-CARRY BAG FOR CANNABIS CONNOISSEURS, IN TIME FOR APRIL 20, CANNABIS CELEBRATION DAY

MJ Attaché

MJ Attaché, a designer and developer of luxury Italian-made leather bags and accessories for the cannabis connoisseur, announced today the official launch of the business. The commencement of MJ Attaché is marked by the introduction of the first-of-its-kind, premium, 100% Italian leather bag, The Anthony, carefully curated for cannabis cache and carry. The Anthony’s debut comes just in time for April 20 th, a day when cannabis is celebrated. MJ Attaché’s bags are market-disrupting; they boast patent-pending modular elements -- not found in any other bag -- that encourage a personalized cannabis experience specific to each one’s individual consumption needs. Catering to both male and female cannabis users, The Anthony’s novel magnetic, re-attachable accessories are fully customizable. Elements inside the bag can be easily added or deleted, depending on what each user prefers for their cannabis self-care ritual. Cleverly crafted by hand in Florence, Italy of the finest Italian leather, The Anthony’s features distinguish it from any other cannabis carry-all bag currently available in the market. Available in five colors, The Anthony bag includes a secure lock closure, removable smooth leather rolling tray, modular elements for customization, such as a pipe case, lighter sleeve, jar sleeve a smell-proof glass jar and a removable, adjustable crossbody strap. The combination of the leather and smell-proof jar aids in disguising odors and keep contents discreet. The MJ Attaché brand challenges outdated, inaccurate stereotypes of cannabis consumers by offering mainstream users a way to elevate their cache-and-carry preferences and experiences. Cannabis has come a long way from its prior perceptions, and MJ Attaché recognizes its broader adoption by users spanning the spectrum. Like many entrepreneurs, ideas are often spurred by personal experience. MJ Attaché is no exception. Founder Christy Fuicelli created the brand and designed its premium bag when she was personally searching for a sophisticated, safe and discreet carry-all solution for her cannabis and accessories. She came up emptyhanded when shopping for options of the same high-quality, sophistication and style to which she was accustomed. Fuicelli believed this void in the marketplace stemmed from stigmas associated with overall cannabis use and she set out to change the market landscape with the design, development and introduction of The Anthony. “I went on a crusade to create a stylish, luxury, handcrafted bag many would be proud to carry. With its impeccable style, quality Italian leather components and customizable modular system, The Anthony bag transcends the outdated “stoner” stereotypes cannabis users are often perceived as and creates the ultimate luxury cannabis experience. I travelled on this journey witnessing nearly a dozen iterations of The Anthony until I was pleased because I could not find a functional, sophisticated, stylish and well-made cannabis transport option, which sparked my interest in developing one myself,” entrepreneur Fuicelli said. “Additionally, I was determined to challenge preconceived notions relating to cannabis use stereotypes. Many people use cannabis medicinally as well as to reduce stress and anxiety and promote relaxation. For me, my cannabis use not only helped alleviate certain medical conditions but also can be directly attributed to the deep creativity it ignited in me, sparking my idea for The Anthony and other bags and accessories in the MJ Attaché product line. I am hoping adoption of The Anthony and other MJ Attaché offerings will simplify the lives of cannabis users around the world. The Anthony truly marks an entry into a market where no other bag like it exists,” Fuicelli concluded. The Anthony, with a price point of $2,150.00, can be purchased here. Looking ahead, MJ Attaché is currently developing other cannabis bag styles and accessories, which are slated for introduction into the marketplace in the latter part of 2024. About MJ Attaché Denver-based MJ Attaché is a designer and developer of high-quality, handmade Italian leather bags and accessories for the cannabis connoisseur. The luxury brand, with its moniker MJ (short for Mary Jane an alias for marijuana), was founded by entrepreneur Christy Fuicelli, a stylish cannabis user. She realized a void in the marketplace to cache and carry her cannabis in a discreet manor reflective of the luxury she enjoyed in other personal products she owned and believed this stemmed from stigmas associated with cannabis use. Determined to bridge this gap, MJ Attaché was born. Fuicelli set out to create a premium bag that would appeal to both male and female cannabis users. She spent years designing and creating beautifully crafted bags that embody elevated style, sophistication, high quality and fine craftmanship. By bringing ease and style to the cannabis industry with her bags, MJ Attaché brings the first accessory of its kind, The Anthony bag, to the marketplace. For more information, visit www.mjattache.com and connect with the Company and its products on Facebook and Instagram. Contact Details PAIRELATIONS, LLC for MJ Attaché Susan J. Turkell +1 303-766-4343 sturkell@pairelations.com

April 17, 2024 10:00 AM Eastern Daylight Time

Image

Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers

Benzinga

By Meg Flippin, Benzinga Theriva™ Biologics (AMEX: TOVX), the clinical-stage immuno-oncology company developing therapies for difficult-to-treat cancers, hit several milestones during 2023, potentially positioning it for a strong year ahead. That could be good news for patients with pancreatic, retinoblastoma, head and neck, brain or ovarian cancers. If Theriva is right, its oncolytic viruses can overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. Its developmental therapies are designed to enable systemic delivery – which means they can target the tumor and distant metastases and have the potential to enhance current standard-of-care therapies, the company says. Theriva’s oncolytic viruses can be administered intravenously or as a direct injection into the tumor or tumor compartment. Trials Underway Announcing its financial results for the full year 2023, Theriva reported ending the year in a good position with VCN-01, its lead therapy candidate. VCN-01 is currently in a phase 2b trial for the treatment of patients with pancreatic ductal adenocarcinoma (PDAC) and in investigator-sponsored studies in a number of indications. As of late March, dosing was underway and enrollment continues to progress for VIRAGE, the randomized, controlled, multicenter open-label phase 2b trial of VCN-01 in combination with standard-of-care chemotherapy as a first-line therapy in newly diagnosed metastatic PDAC patients. The trial is targeting enrollment of 92 evaluable patients and the company reports it's on track to complete enrollment in the first half of this year. Patients are being enrolled in six sites in the U.S. and nine in Spain and will continue without any changes to the protocol after an evaluation by the Independent Data Monitoring Committee (IDMC) found no safety concerns. Intravenous VCN-01 has been well tolerated and demonstrated a safety profile consistent with prior clinical trials, Theriva reports. Importantly, it said no additional toxicities were observed in patients receiving a second dose of VCN-01. That means repeated systemic dosing of VCN-01 is feasible from a safety perspective, paving the way for Theriva to focus on whether the repeated dose VCN-01 regimen may lead to improved clinical outcomes for patients. “We believe VCN-01’s differentiated mechanism of action has the potential to address the urgent need for new treatment options for patients with PDAC by degrading the tumor matrix and increasing tumor access by VCN-01 and co-administered cancer therapies,” said Theriva CEO Steven Shallcross during a conference call to discuss full year 2023 earnings. To date, more than 100 patients have been dosed with VCN-01 in clinical trials in patients with a broad range of cancers, including PDAC, retinoblastoma, colorectal cancer and head and neck squamous cell carcinoma (HNSCC). Additional investigator-sponsored studies have been initiated in patients with brain cancers and ovarian cancers. Beyond Pancreatic Cancer Treating pancreatic cancer with VCN-01 isn’t the only area Theriva focused on during the year. The company is also engaged in a phase 1 trial evaluating the safety and activity of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma. That trial is making progress, with the company completing patient treatment. The trial is designed to evaluate escalating doses of VCN-01 administered by two intravitreal injections separated by 14 days. The investigator-sponsored phase 1 trial will complete patient follow-up in the first half of 2024, and the results will help inform the planned phase 2 trial design, Theriva says. Additionally, the University of Pennsylvania continues to enroll and treat patients in their phase 1 investigator-sponsored trial administering VCN-01 with huCART-meso cells to patients with ovarian or pancreatic cancers. VCN-01 is designed to increase tumor immunogenicity and improve access by additional therapies such as huCART-meso cells. Dosing is also underway for the ongoing phase 1b/2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant (HCT) recipients for the prevention of acute graft-versus-host-disease (aGVHD). Theriva said SYN-004 appears to be well tolerated. Collaborating And Expanding Partnerships Not one to rest, Theriva was also busy during the year expanding collaborations and identifying new areas that may benefit from VCN-01. Late last year it signed an exclusive option to license intellectual property from Sant Joan de Déu-Barcelona Children’s Hospital (SJD) to explore the therapeutic potential of VCN-01 in combination with topoisomerase I inhibitors. This strengthens a long-term research collaboration with SJD and builds on an ongoing trial evaluating VCN-01 in pediatric cancers. The company is also pursuing licensing discussions for its SYN-020 intestinal alkaline phosphatase asset. SYN-020 is a recombinant bovine intestinal alkaline phosphatase (IAP) formulated for oral delivery to the small intestine and designed to diminish fat absorption and intestinal inflammation, tighten the gut barrier to mitigate “leaky gut” and promote a healthy microbiome. It has the potential to become a multi-indication therapeutic capable of addressing disorders stemming from gastrointestinal (GI) inflammation. Theriva is doing all this and keeping costs down. For the year ended December 31, 2023, general and administrative expenses decreased 28% to $7.1 million from $9.9 million in the year-earlier period. Meanwhile, the company increased spending on research and development by 22%, with an eye on the future based on an observed uptick in demand for its compounds. “In 2023, we continue to make steady progress to drive forward our oncology-focused portfolio designed to address unmet needs for difficult-to-treat cancers,” said Shallcross on the earnings call. “Our primary efforts and resources are focused on pursuing multiple therapeutic opportunities for our lead clinical candidate VCN-01. We'll continue to look for ways to drive additional value for our shareholders and for the long-term success of what we're trying to do, namely delivering promising treatments for very, very difficult-to-treat cancers.” Featured photo by National Cancer Institute on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

April 17, 2024 08:30 AM Eastern Daylight Time

Image

Companies Like SHEIN Are Working With Airwallex – Here’s Why, & How It Could Help Your Business

Airwallex

By Meg Flippin, Benzinga Thanks to the proliferation of social media and e-commerce, small businesses are no longer local players but can cater to customers across the globe. But for many, growing without borders and doing business in far-flung corners of the world can be costly thanks to antiquated banks that charge inflated fees and make transacting in multiple currencies and payment methods cumbersome. That can hamper growth and dampen global ambitions for some small and medium-sized businesses. The good news is that the old way of managing finances for global small and medium businesses is being flipped on its head thanks to Airwallex and its global business account. The Melbourne-founded financial technology company was built with a single purpose – to empower businesses with the ability to collect, manage and spend funds all over the world. And it’s doing precisely that with its global business account. Leveling The Playing Field A one-stop solution for small businesses, Airwallex’s borderless business account enables enterprises to pay suppliers, manage team expenses and accept payments from around the world with just one account. Using the account, business owners can collect and hold multiple currencies without paying any monthly fees or meeting a minimum requirement, and they can offer shoppers several different local payment options no matter where their customers are in the world. Airwallex says it distinguishes itself by providing businesses the capability to accept payments from customers in their local currency and consolidating all transactions on your accounting platform. It also integrates with e-commerce marketplaces like Amazon (NASDAQ: AMZN) and TikTop Shop or platforms like Shopify (NYSE: SHOP) or WooCommerce Additionally, Airwallex says it can send funds more affordably and efficiently than traditional banks – it has a large geographical reach and can have payments in over 150+ countries and regions in 60+ currencies while providing the advantage of converting funds at more competitive exchange rates compared to banks. But the fintech doesn’t stop there. Its borderless Visa (NYSE: V) cards come with zero international fees. If that isn’t enough, its mobile app enables business owners to upload receipts for approval, reconcile expenses in one place, sync with your account systems like Xero, and get an overview of finances in real time. Click here to see how businesses use Airwallex to save money and expand. Filling An Unmet Need Airwallex is addressing a market that has long been ignored by traditional banks that deem small businesses too small and too risky to transact with. But they are also the backbone of the U.S. and global economy and are growing by leaps and bounds thanks to technology. In 2022, the global small-business market was valued at $119.35 billion. By 2030, it is projected to reach $229.2 billion, growing at a CAGR of 8.5%. Meanwhile, global commerce is taking off big time with 54% of global consumers expected to increase their cross-border purchasing in the next six to twelve months, according to Airwallex. Of that group, 77% would abandon their cart if their preferred payment method wasn’t offered. It is for those reasons that Airwallex is doing such brisk business. The company reports over 100,000 customers, has an annual transaction volume of over $60 billion, and can help its businesses accept payments from major credit card schemes and more than 160 local payment methods. Using its platform, small and medium-sized businesses can open domestic and foreign currency accounts within minutes to collect payments from worldwide customers. What’s more, Airwallex says it can save businesses up to 80% in foreign exchange fees, and the majority of funds arrive on the same day. That is important to businesses that need quick access to cash flow to continue to grow operations. Since launching in 2015, the company says it has raised $900 million in venture funding at a valuation of $5.6 billion, with big-name investors including Sequoia, DST Global, Greenoaks Capital, Salesforce Ventures, LonePine Capital, Square Peg Capital and 1835i Ventures (ANZ Bank). Timing Is Everything It only makes sense that companies like Airwallex would level the playing field, leveraging technology to empower companies to conduct business cheaper, bigger and better. “E-commerce is more global than ever,” said Kai Wu, Chief Revenue Officer at Airwallex, and, “Despite ongoing economic uncertainty and slowing global growth, it is clear that consumer spending will continue to grow. With the global cross-border e-commerce market set to reach $7.9 trillion by 2030, it is critical for international merchants to solve consumer pain points and deliver the best possible customer experience to thrive in this competitive market.” Airwallex customers, including SHEIN, GOAT and Campilify, are already thriving. SHEIN, the global fashion and lifestyle e-retailer, for example, is using Airwallex to collect online payments from its customers in more than 150 countries worldwide. With shoppers paying in multiple currencies and payment methods, by using Airwallex, SHEIN was able to eliminate costly conversion fees and streamline payouts to its global base of sellers. The same story is playing out for GOAT, an online seller of used and new sneakers, and Campilify, Australia’s largest campervan, motorhome and caravan-sharing company. But it’s not just brand names that are benefiting from Airwallex. The company reports that even smaller enterprises are experiencing significant savings through its platform. Take Two More Glasses, the Hong Kong leading fine wine and spirits e-retailer and importer across Asia Pacific, as one example. Since using Airwallex, its global revenue has increased by 30% largely because the tool is easier, cheaper and faster for overseas customers to pay with. Then there’s CROSSNET, the Miami, Florida-based maker of a four-way volleyball net. Since using Airwallex, the company said it expects to save more than $2,000 a month in fees, saving an extra $24,000 a year. The world is becoming borderless and so is online shopping. Banks are ignoring the small and medium businesses doing brisk business in all corners of the world. Airwallex isn’t. It is stepping up to fill a void, leveraging technology to level the playing field – and companies across the globe are taking notice. To learn more about how Airwallex works, click here. Featured photo by Ibrahim Boran on Unsplash. Airwallex is a leading global financial platform for modern businesses, offering trusted solutions for global payments, treasury and expense management, and embedded finance. With our proprietary infrastructure, Airwallex removes the friction from global payments and financial operations, allowing businesses of all sizes to unlock new opportunities and grow beyond borders. Proudly founded in Melbourne, Airwallex powers over 100,000 businesses globally and is trusted by brands such as Brex, Rippling, Navan, Qantas, SHEIN and many more. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details David Zhao David.Zhao@airwallex.com Company Website https://www.airwallex.com/us

April 17, 2024 08:25 AM Eastern Daylight Time

Image

M.A.S. Construction Ltd. Announces Innovative Color Consultation Services for Newmarket Residents

Rev Up Marketers

M.A.S. Construction Ltd., a leading painting contractor in Newmarket and the surrounding areas, is pleased to announce the launch of its new color consultation service. This innovative program is designed to assist homeowners in navigating the often-daunting process of selecting the perfect paint colors for their interior spaces. Choosing paint colors can be a challenging task. With a vast array of options available, homeowners may feel overwhelmed by the sheer number of colors and finishes to consider. House Painters in Newmarket, like M.A.S. Construction Ltd. recognizes this challenge and is committed to providing its clients with the tools and support they need to make informed decisions. Their color consultation service pairs homeowners with a professional interior designer who will guide them through the color selection process. During the consultation, the designer will gain a comprehensive understanding of the homeowner's vision for the space. This includes factors such as the desired aesthetic, the functionality of the room, and the existing furniture and décor. The designer will then introduce the homeowner to the fundamental concepts of color theory, explaining the impact of different colors on the overall ambiance of a space. They will discuss the various paint finishes available, such as gloss, satin, and matte, outlining the unique properties of each finish and its suitability for different applications. With their expertise, the designer will help the homeowner explore a curated selection of colors that complement the existing architecture and décor of the space. They will present color samples and guide the homeowner in visualizing how the colors will appear in the finished product, taking into account the natural and artificial lighting conditions. The color consultation service goes beyond simply selecting paint colors. The designer will also provide expert advice on color coordination throughout the home, ensuring a cohesive and aesthetically pleasing flow between rooms. They can offer suggestions for complementary accent colors and trim paints, creating a unified and visually appealing living space. The company believes that a well-considered color palette is essential for creating a comfortable and inviting home environment. Their new color consultation service empowers Newmarket residents to make informed decisions about their painting projects, resulting in beautiful and functional living spaces that reflect their unique style. For any press-related queries or additional details, please mail to info@mascons.ca or visit https://www.mascons.ca/. About M.A.S. Construction Ltd. M.A.S. Construction Ltd. is a reputable painting contractor serving Newmarket and the surrounding areas. The company is committed to providing exceptional customer service, high-quality workmanship, and a wide range of painting services to meet the needs of residential and commercial clients. Contact Details M.A.S. Construction ltd. Muharrem Sandirli +1 647-835-0590 pr@aestheticsmarketing.com Company Website https://www.mascons.ca/

April 17, 2024 08:08 AM Eastern Daylight Time

Image

Japan’s Premier Clinical CRO A2 Healthcare, an ITOCHU Subsidiary, Launches US Expansion

A2 Healthcare

A2 Healthcare, ITOCHU Corporation’s (ITOCY) leading subsidiary in healthcare headquartered in Tokyo, Japan, announced its US expansion. Leveraging regulatory strategy and clinical development expertise in Japan and Taiwan on a global scale, A2 Healthcare aims to transform the Japanese drug market, the third largest in the world. The company will support new drug development in Japan by expanding its partnerships with biotech and pharmaceutical companies based in the United States, the world leader in biopharmaceutical R&D. The United States accounts for around a third of the global market, according to the Pharmaceutical Research and Manufacturers Association (PhRMA). A2 Healthcare President and CEO Hitoshi Kamiya is confident that the Boston branch will help US companies navigate the Japanese market. “Pharmaceutical companies shy away from the Japanese market due to Japan’s strict pharmaceutical regulations, complex clinical trial-related procedures, and drug pricing system that differs from Europe and the United States. Hence, fewer new drugs enter the Japanese market, creating ‘drug loss.’ In 2020, 72 percent of drugs approved in Europe and the United States were not approved in Japan,” said Kamiya. “Unfortunately, this rate is on the rise. More than half of the domestically unapproved drugs in Japan are developed by biotech companies overseas. With the launch of the US office in Boston, A2 Healthcare is optimally positioned to change this narrative. We are offering a new mechanism to eliminate drug loss by encouraging companies to develop drugs in Japan at ease.” As a top CRO in Japan, A2 Healthcare has successfully supported new drug development, including a large number of sponsor-initiated clinical trials and investigator-initiated studies in various fields and diseases. A2 Healthcare’s advanced use of IT in its innovative clinical trials and high patient enrollment results in Japan were recognized with the “Best CRO/CDMO” prize from the Citeline Pharma Intelligence Awards Japan in October 2023. The Boston metropolitan area is an ideal networking environment as part of the world's largest biotech cluster with more than 1,000 biotech companies working on new drug development pipelines. A2 Healthcare will also offer its Pipeline Accelerator Program, a financing program for these companies. Hiroki Matsushima, head of A2 Healthcare’s Global Business Expansion in charge of the US Boston Office, stated, “Boston is the perfect location for launching global CRO services for new drug development in Japan, especially in supporting the development of drugs highly sought after by Japanese patients.” He added, “Japan is a country with a population of over 120 million people and an average lifespan of 84 years. In clinical trials, patient compliance is very high, while the drop-out rate is low. Sustained by a large patient pool for most target indications, Japan remains one of the most attractive and cost-effective places to implement global drug development plans. Additionally, Japan's low inflation over the past decades has helped keep costs down, unlike in most other countries.” A trusted partner for the global life science, medical and pharmaceutical industries, A2 Healthcare offers the most efficient regulatory pathway in Japan for new drug development and regulatory submissions to gain approval. Combining extensive clinical experience and 84 million patient data from 97,000 Japanese sites in the company’s own database, A2 Healthcare has recently achieved a 96 percent enrollment compliance rate within the agreed schedule, setting an impressive standard in the CRO industry. For more information about A2 Healthcare’s services and to request business meetings, contact the Boston Office at matsushima-h@a2healthcare.com or +1(857) 265-0605. ### About A2 Healthcare Corporation A2 Healthcare Corporation, an ITOCHU company, is a premier clinical contract research organization (CRO) founded in 2003 to enhance the quality of lives. Specializing in global clinical trial and research services, we support the development of new drug treatments across wide-ranging therapeutic areas and modalities. A2 Healthcare operates in the United States, Japan and Taiwan, leading the industry by providing best-in-class quality and deliverables through its clinical operations. For more information, visit www.a2healthcare.com/en. Media Contact: A2 Healthcare US Boston Office Hiroki MATSUSHIMA matsushima-h@a2healthcare.com +1(857) 265-0605 A2 Healthcare Japan PR: marke@a2healthcare.com Investor Relations: watanabe-se@a2healthcare.com Contact Details A2 Healthcare US Boston Office Hiroki MATSUSHIMA +1 857-265-0605 matsushima-h@a2healthcare.com

April 17, 2024 08:04 AM Eastern Daylight Time

News Release

VIVOPOWER EXECUTIVE CHAIRMAN AND CEO FILES FORM F4 TO INCREASE HIS SHAREHOLDING TO 12.3%

VivoPower International PLC

VivoPower International PLC (NASDAQ: VVPR, “VivoPower”, the “Company”) has announced that Executive Chairman and CEO, Kevin Chin, is increasing his individual shareholding in the Company by 146,084 shares, representing approximately 4.4% of the undiluted number of issued and outstanding shares of the Company. This is through a voluntary election to receive his CEO salary from 1 July 2023 until 30 June 2024, in the form of ordinary shares in VivoPower, for which the issuance of VivoPower shares for the period from 1 July 2023 to 31 March 2024 has been approved by the Remuneration Committee. The number of shares noted above represents CEO compensation for the 9 month period to 31, 2024, with Kevin Chin also having elected in November 2023 to receive his CEO salary for the full financial year ending June 30, 2024 in the form of VivoPower ordinary shares. The shares to be issued for the quarter ending 30 June 30, 2024 will be subject to Remuneration Committee approval immediately after the end of that quarter. About VivoPower VivoPower is an award-winning global sustainable energy solutions B Corporation company focused on electric solutions for customised and ruggedised fleet applications, battery and microgrids, solar and critical power technology and services. The Company’s core purpose is to provide its customers with turnkey decarbonisation solutions that enable them to move toward net-zero carbon status. VivoPower has operations and personnel in Australia, Canada, the Netherlands, the United Kingdom, the United States, the Philippines, and the United Arab Emirates. Forward-Looking Statements This communication includes certain statements that may constitute “forward-looking statements” for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterisations of future events or circumstances, including any underlying assumptions. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, the anticipated impact that the events or transactions described in this communication may have on the Company and the expected returns therefrom. These statements are based on VivoPower’s management’s current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower’s business. These risks, uncertainties and contingencies include changes in business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, changes in general economic conditions, geopolitical events and regulatory changes, expectations on funding from investors, and other factors set forth in VivoPower’s filings with the United States Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise. Contact Details Shareholder Enquiries shareholders@vivopower.com Company Website https://vivopower.com/

April 17, 2024 07:30 AM Eastern Daylight Time

News Release

Bitget has onboarded over 2.5M users in MENA region in the past six months

Bitget

Bitget, the world's leading cryptocurrency exchange and Web3 company, has released a report on the growth recorded in the Middle East and North African regions since its launch in November 2023. With over 2.5M users from the region alone, Bitget has now reached 25M users worldwide. Last year, Bitget announced its expansion into the Middle East region with plans to establish its regional hub in the UAE and hire 60 employees as part of its global scaling strategy. In the last six months, Bitget has grown its MENA trading volumes by over 500% from its initial launch, aiming to bring in more localized solutions for its users. Sam A Spiers, Regional Director for Bitget MENA, states: “Bitget will strengthen its operations in the MENA region, leveraging the region's high adoption rates and crypto-friendly landscape. We are exploring blockchain and crypto projects to support home-ground projects for listing and providing more exposure to Middle Eastern founders and products.” In February 2024, Bitget Research released a Bitcoin Halving report that highlighted over 80% of MENA investors considered the halving to have a significant price impact, while the recent Bitcoin bull run to renew its all-time high value was anticipated by 88% of respondents — more than in any other region. The is higher optimism in comparison to the survey’s other regional participants, as MENA users were the most willing to increase their crypto holdings, with 82% reporting affirmatively. In contrast, the global average didn’t exceed 70%. As part of its focus on the MENA region, Bitget has Arabic lingual support for its website and mobile application. Bitget users in the Middle East also benefit from zero fees for buying and selling cryptocurrencies through Bitget P2P, aiming to ensure a seamless and user-friendly experience for traders. This week Bitget partnered up with OnRamp, a leading crypto payment solution provider allowing its users to buy and sell crypto using various local currencies, including AED and other fiat currencies. “With the MENA region representing a significant share of the global crypto transaction volume in 2023, it is poised to grow exponentially in the years to come. Bitget has already begun exploring license applications to operate in target Middle East markets. It's our priority to obtain operating licenses and support our users with a secure WEB3 platform.” Gracy Chen, Managing Director of Bitget. Bitget has been expanding its operational reach globally in recent months, including registering as a VASP (Virtual Asset Service Provider) in Poland and obtaining similar crypto registration in Lithuania. The new expansion plan in the Middle East compliments its launch in Türkiye, which now features full localization, including its Turkish website Bitgettr.com featuring tailored services for users in Türkiye. Bitget's growth plans go hand-in-hand with creating a seamless ecosystem of crypto products for users locally. By personalizing the platform offerings, Bitget recently launched a Ramadan campaign to celebrate the holy month with its users. Additionally, Bitget offers 0 fees for buying Bitcoin and Ethereum on spot trading along with free bank transfers. About Bitget Established in 2018, Bitget is the world's leading cryptocurrency exchange and Web3 company. Serving over 25 million users in 100+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions. Formerly known as BitKeep, Bitget Wallet is a world-class multi-chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, swap, NFT Marketplace, DApp browser, and more. Bitget inspires individuals to embrace crypto through collaborations with credible partners, including legendary Argentinian footballer Lionel Messi and official eSports events organizer PGL. For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord | Bitget Wallet Contact Details PR Team media@bitget.com Company Website https://www.bitget.com/

April 17, 2024 07:04 AM Eastern Daylight Time

1 ... 231 232 233 234 235 ... 3725

Back